// App-Quantinova.ai

: Therapeutic Effect of Bortezomib Combined with Dag Regimen in Hyperleukocytic Acute Myeloid Leukemia

Researchers

Presenter

  • Xinqi Li

Principal Investigators

  • Jinxian Wu

  • Xiaoyan Liu

  • Fuling Zhou

Medical Centers

  • Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Doxorubicin

  • Bortezomib

  • Cytarabine liposomal

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved